Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials by Abdelrahman Ibrahim Abushouk, Ahmed Elmaraezy, Amro Aglan, Reham Salama, Samar Fouda, Rana Fouda, Ammar M. AlSafadi

Get full text